![Per Wold-Olsen](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Per Wold-Olsen
Voorzitter bij
ONCOPEPTIDES AB
Vermogen: 927 883 $ op 31-05-2026
Profiel
Per Wold-Olsen is een Noorse zakenman die aan het hoofd heeft gestaan van 8 verschillende ondernemingen. Momenteel is hij voorzitter van GN Store Nord A, voorzitter van GN Audio A, voorzitter van GN Hearing An en voorzitter van GN Netcom A (allemaal dochterondernemingen van GN Store Nord A) en voorzitter van Oncopeptides AB. Hij is ook lid van de raad van bestuur van Gilead Sciences, Inc. en Bio Malter en voorzitter van MMV Medicines for Malaria Venture. Daarvoor was hij President van de Intercontinentale Divisie bij Merck & Co, Inc. en Chief Executive Officer van MSD (Norge) AS (een dochteronderneming van Merck & Co, Inc.), Regionaal Directeur en Vice President van MSD Scandinavia AS en Voorzitter van de Raad van Toezicht van H. Lundbeck A. Hij behaalde een MBA aan de Universiteit van Wisconsin en een MBA aan de BI Norwegian Business School.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
SENZIME AB 0,72% | 23-09-2025 | 1.126.344 ( 0,72% ) | 605 061 $ | 31-05-2026 |
ONCOPEPTIDES AB 0,42% | 09-06-2026 | 1.646.802 ( 0,42% ) | 322 823 $ | 31-05-2026 |
Laatste nieuws over Per Wold-Olsen
Actieve functies van Per Wold-Olsen
| Bedrijven | Functie | Begin |
|---|---|---|
| ONCOPEPTIDES AB | Voorzitter | 17-05-2018 |
| SENZIME AB | Voorzitter | 01-11-2023 |
Bio Malter | Directeur/Bestuurslid | - |
Forepont Capital LLC
 Forepont Capital LLC Investment ManagersFinance Forepont Capital Partners invests in companies located in United States, western Europe, Singapore, Australia, and Israel. The firm focuses on sectors such as biotech, medtech, and e-health. It participates in early-stage transactions. | Directeur/Bestuurslid | - |
GN Hearing A/S
 GN Hearing A/S Medical SpecialtiesHealth Technology Manufactures hearing-aid devices | Voorzitter | 16-06-2008 |
MMV Medicines for Malaria Venture
 MMV Medicines for Malaria Venture Miscellaneous Commercial ServicesCommercial Services Develops antimalarial drugs | Voorzitter | - |
Eerdere bekende functies van Per Wold-Olsen
| Bedrijven | Functie | Einde |
|---|---|---|
| GN STORE NORD A/S | Voorzitter | 15-03-2023 |
| AMARIN CORPORATION PLC | Voorzitter | 28-02-2023 |
| H. LUNDBECK A/S | Voorzitter | 30-03-2011 |
| ░░░░░░░░ ░░░░░░ ░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░░░░ ░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Opleiding van Per Wold-Olsen
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
98
Eerstegraads connecties
23
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 23 |
|---|---|
Gilead Sciences, Inc.
 Gilead Sciences, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes therapeutic products and treatments for life threatening diseases | Health Technology |
Merck & Co., Inc.
 Merck & Co., Inc. Pharmaceuticals: MajorHealth Technology Manufactures human and animal health pharmaceutical products & vaccines | Health Technology |
Amarin Corp. Plc
 Amarin Corp. Plc Pharmaceuticals: MajorHealth Technology Operates as biopharmaceutical company which develops and commercializes therapeutics to improve cardiovascular health | Health Technology |
Royal Numico NV
 Royal Numico NV Food: Specialty/CandyConsumer Non-Durables Manufactures baby food and clinical nutrition products | Consumer Non-Durables |
inVentiv Health Clinical, Inc.
 inVentiv Health Clinical, Inc. Miscellaneous Commercial ServicesCommercial Services Provides clinical research and drug development services | Commercial Services |
H. Lundbeck A/S
 H. Lundbeck A/S Pharmaceuticals: MajorHealth Technology Engages in the research, development, production and sale of pharmaceuticals for the treatment of brain diseases | Health Technology |
Glyconix Corp.
 Glyconix Corp. Pharmaceuticals: MajorHealth Technology Manufactures anti infective and oncology drugs | Health Technology |
Senzime AB
 Senzime AB Medical SpecialtiesHealth Technology Develops and markets an enzyme based biosensor technology | Health Technology |
GN Store Nord A/S
 GN Store Nord A/S Telecommunications EquipmentElectronic Technology Provides telecommunications and hearing instruments | Electronic Technology |
GN Audio A/S
 GN Audio A/S Electronic Production EquipmentElectronic Technology Develops, manufactures, and markets corded and wireless headsets, amplifiers for headsets, and headset telephones | Electronic Technology |
GN Hearing A/S
GN Hearing A/S Medical SpecialtiesHealth Technology Manufactures hearing-aid devices | Health Technology |
University of Wisconsin
 University of Wisconsin Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Oncopeptides AB
 Oncopeptides AB Pharmaceuticals: MajorHealth Technology Develops chemotherapeutic pharmaceuticals of compounds for cancer treatment | Health Technology |
Exiqon A/S
 Exiqon A/S Miscellaneous Commercial ServicesCommercial Services Engages in the pharmaceutical industry | Commercial Services |
BI Norwegian Business School
 BI Norwegian Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
World Growth | |
MMV Medicines for Malaria Venture
MMV Medicines for Malaria Venture Miscellaneous Commercial ServicesCommercial Services Develops antimalarial drugs | Commercial Services |
PharmaSet SAS
 PharmaSet SAS Medical SpecialtiesHealth Technology Manufactures and distributes disposable healthcare kits for hospital use | Health Technology |
MSD (Norge) AS
 MSD (Norge) AS Pharmaceuticals: MajorHealth Technology Engages in researching, manufacturing and marketing of drugs | Health Technology |
Bio Malter | |
MSD Scandinavia AS | |
Novo Holdings A/S (Investment Company)
 Novo Holdings A/S (Investment Company) Financial ConglomeratesFinance Novo Holdings-IC aims to improve people’s health and the sustainability of society and the planet by generating attractive long-term returns on the assets of the Novo Nordisk Foundation. The firm invests in almost all life science segments including pharmaceuticals, biotechnology, medical technology, healthcare services and industrial BioSolutions. Outside of the life sciences they invest in a diversified portfolio of equities, fixed income, real assets and alternatives. | Finance |
Forepont Capital LLC
Forepont Capital LLC Investment ManagersFinance Forepont Capital Partners invests in companies located in United States, western Europe, Singapore, Australia, and Israel. The firm focuses on sectors such as biotech, medtech, and e-health. It participates in early-stage transactions. | Finance |
